Hyaluronic Acid Dermal Filler Sales

Hyaluronic Acid Dermal Filler Sales Market Outlook

The global Hyaluronic Acid Dermal Filler market is projected to reach USD 7.42 billion by 2035, with a robust CAGR of 10.3% from 2025 to 2035. Factors contributing to this significant growth include an increasing number of non-surgical cosmetic procedures, a growing aging population, and rising awareness regarding aesthetic enhancements among consumers. Additionally, advancements in technology and product formulations are fostering innovations that cater to varied consumer needs, leading to an expanded market reach and enhanced product visibility. The trend of minimally invasive procedures coupled with the rising focus on personal aesthetics and self-care is further propelling the demand for hyaluronic acid dermal fillers across various demographics. Furthermore, the increased acceptance of cosmetic procedures by both men and women is expected to drive substantial growth in this market.

Growth Factor of the Market

Several key factors contribute to the growth of the Hyaluronic Acid Dermal Filler market, notably the increasing demand for non-surgical aesthetic procedures that provide quick results with minimal downtime. As more individuals seek alternatives to invasive cosmetic surgery, the preference for dermal fillers has surged, creating a significant market opportunity. Additionally, advancements in hyaluronic acid formulations, which enhance the product's efficacy and longevity, are attracting a broader consumer base. The rising awareness of aesthetic treatments, fueled by social media and celebrity endorsements, has further popularized these products, especially among younger demographics looking for preventive solutions against aging. Moreover, the integration of high-quality manufacturing practices and stringent regulatory frameworks has bolstered consumer confidence in these products, leading to increased adoption in both clinical and retail environments.

Key Highlights of the Market

• The market is experiencing rapid growth due to the rising popularity of non-invasive aesthetic treatments.
• Technological advancements in dermal filler formulations are enhancing product performance.
• Increasing awareness and acceptance of aesthetic procedures are influencing consumer behavior.
• The market is characterized by a diverse range of product types catering to various cosmetic needs.
• Regional variations show significant growth potential, especially in Asia Pacific and North America.

By Product Type

Single-Phase:

Single-phase hyaluronic acid dermal fillers consist of a uniform gel-like consistency, making them ideal for providing a smooth and natural-looking effect. These fillers are primarily used for subtle enhancements like wrinkle reduction and facial contouring, allowing for precise applications. Their homogeneous structure enables the product to integrate seamlessly into the skin, minimizing the risk of lumps and ensuring a flawless finish. The simplicity of formulation also leads to easier administration by practitioners, contributing to their increasing popularity in cosmetic procedures. Furthermore, their versatility makes them suitable for various facial areas, including the nasolabial folds and marionette lines, thus broadening their application scope in aesthetic treatments.

Dual-Phase:

Dual-phase hyaluronic acid dermal fillers embody a unique formulation that combines both cohesive and non-cohesive components, resulting in a product that offers both volume and flexibility. This distinct composition allows practitioners to achieve a more defined lift while also maintaining a natural appearance, making it particularly suitable for areas requiring more substantial augmentation, such as the cheeks and jawline. The dual-phase nature of these fillers aids in the maintenance of structure over time, as they provide the necessary support while allowing for dynamic movement of facial expressions. As a result, they are increasingly favored for applications demanding a balance between volume restoration and facial dynamics, making them a popular choice among aesthetic professionals.

Reverse-Phase:

Reverse-phase hyaluronic acid fillers are characterized by their unique manufacturing process, which allows them to achieve higher viscosity and longer-lasting effects. These fillers are particularly beneficial for areas requiring significant volumization, such as deep wrinkles or hollows under the eyes. Their ability to provide a lifting effect while also retaining moisture makes them an attractive option for those seeking lasting results without the need for frequent touch-ups. Furthermore, reverse-phase fillers often exhibit fewer side effects and provide improved overall satisfaction for both practitioners and patients. The growing demand for long-lasting solutions in cosmetic treatments has significantly contributed to the uptake of reverse-phase hyaluronic acid dermal fillers in the aesthetic market.

Cross-Linked:

Cross-linked hyaluronic acid fillers are created through a chemical process that links the hyaluronic acid molecules, enhancing stability and longevity. This technology allows these fillers to resist degradation and provide sustained results, making them ideal for various applications such as wrinkle correction and lip enhancement. The cross-linking process not only prolongs the filler’s effectiveness but also improves its ability to retain moisture within the skin, contributing to a more youthful appearance. These fillers are widely regarded for their ability to provide volume and structure, which is essential in maintaining facial harmony. As patients increasingly seek long-lasting and impactful results, cross-linked hyaluronic acid dermal fillers are becoming a staple in the aesthetic industry.

Non-Cross-Linked:

Non-cross-linked hyaluronic acid fillers are typically used for more superficial applications, such as hydration and minor corrections. Their formulation allows for easier integration within the skin, providing a smooth and natural look while delivering hydration to the targeted areas. These fillers are particularly popular for treating fine lines and enhancing areas like the lips with less emphasis on volumization. While they may not provide the longevity seen with cross-linked options, they are often chosen for their versatility and ease of use in various procedures. As trends shift towards more natural looks and treatments, non-cross-linked hyaluronic acid dermal fillers have found a firm place in the market, appealing to individuals seeking subtle enhancements without the commitment of longer-lasting solutions.

By Application

Wrinkle Correction:

Wrinkle correction is one of the primary applications of hyaluronic acid dermal fillers, addressing various signs of aging such as fine lines, crow's feet, and deeper wrinkles. The hydrating properties of hyaluronic acid help plump the skin, effectively reducing the appearance of wrinkles and restoring a youthful look. These fillers offer immediate results, with minimal downtime, making them highly desirable among consumers looking for quick and efficient solutions. The growing aging population, coupled with increasing awareness of non-surgical treatments, is significantly driving the demand for wrinkle correction treatments. As aesthetic preferences continue to evolve towards natural-looking results, hyaluronic acid fillers are being formulated to provide subtle enhancements that can seamlessly integrate into the skin.

Lip Augmentation:

Lip augmentation has gained immense popularity, with hyaluronic acid fillers being a preferred choice for enhancing lip volume and definition. These fillers allow for precise contouring and shaping, enabling practitioners to create fuller, more voluptuous lips while maintaining a natural appearance. The hydrophilic nature of hyaluronic acid means that it attracts moisture, providing plumpness and hydration to the lips. Moreover, the minimal invasiveness of the procedure and the quick recovery time contribute to its appeal among younger demographics seeking to enhance their aesthetic without commitment. As trends lean towards fuller lips, the demand for hyaluronic acid dermal fillers in lip augmentation continues to rise.

Cheek Filling:

Cheek filling applications utilize hyaluronic acid fillers to restore volume and contour to the mid-face area, which can diminish with age. As individuals age, the loss of subcutaneous fat and bone structure can lead to a sunken appearance; thus, cheek fillers play a vital role in enhancing facial symmetry and overall aesthetics. By providing lift and definition to the cheeks, these fillers can enhance the youthful contour of the face, leading to a more vibrant and rejuvenated look. The versatility of hyaluronic acid allows for tailored treatments that meet individual needs while ensuring natural results. Cheek filling procedures are often combined with other treatments, such as wrinkle correction, making them a popular option in comprehensive cosmetic enhancement plans.

Scar Treatment:

Hyaluonic acid fillers are increasingly being employed in scar treatment, specifically for atrophic scars, which can affect individuals’ confidence and self-esteem. The filler works by elevating the depressed areas of scar tissue, leading to a smoother skin surface and a more uniform appearance. This application has gained traction as aesthetic medicine evolves, with more practitioners recognizing the potential of dermal fillers beyond traditional cosmetic enhancements. The minimally invasive nature of these treatments, paired with the rapid recovery time, makes hyaluronic acid fillers an appealing option for scar correction. As awareness of such applications rises, the market for hyaluronic acid fillers in scar treatment is expected to grow significantly.

Others:

The "Others" category encompasses various applications of hyaluronic acid dermal fillers that may not fall under the main classifications. These can include non-surgical nose reshaping, hand rejuvenation, and augmentation of areas like the temples or chin. The versatility of hyaluronic acid allows practitioners to innovate and adapt treatments to meet patient needs. As more practitioners become skilled in the use of dermal fillers for unique applications, the market for these fillers continues to expand. The growing trend of customizing aesthetic treatments is significantly influencing the demand for hyaluronic acid fillers across diverse applications, making it an exciting area within the beauty and cosmetic industry.

By Distribution Channel

Hospitals:

Hospitals serve as a significant distribution channel for hyaluronic acid dermal fillers, particularly for medically supervised aesthetic procedures. Many hospitals offer cosmetic services that include the administration of these fillers, ensuring that patients receive treatments in a regulated environment with qualified medical professionals. The presence of dermatologists and plastic surgeons in hospitals often leads to greater trust and credibility, driving patients to seek enhancements in such settings. Moreover, hospitals tend to have comprehensive patient care systems, integrating follow-up and additional treatments, which can enhance patient satisfaction and retention. As the trend towards safe, medically supervised aesthetic procedures continues, the hospital channel is poised for growth in the hyaluronic acid dermal filler market.

Dermatology Clinics:

Dermatology clinics play a pivotal role in the distribution of hyaluronic acid dermal fillers, as they specialize in skin health and aesthetic enhancements. These clinics provide a wide range of cosmetic services, including filler injections, under the guidance of certified dermatologists who possess in-depth knowledge of skin anatomy and aesthetics. The focused expertise in dermatology allows practitioners to assess individual skin types and customize treatments accordingly, ensuring optimal results. As consumers increasingly seek specialized care for their aesthetic needs, dermatology clinics are becoming a preferred destination for hyaluronic acid filler procedures. Additionally, the personalized approach within these clinics aids in building long-term relationships with clients, further driving market demand.

Online Retailers:

The emergence of online retailers has revolutionized the distribution landscape for hyaluronic acid dermal fillers, making products more accessible to consumers. Consumers now have the convenience of browsing a wide variety of product options from their homes, enabling them to compare brands, read reviews, and make informed purchasing decisions. The growth of e-commerce has also paved the way for many manufacturers to reach a broader audience without geographical constraints. However, purchasing dermal fillers online comes with its challenges, including the need for proper storage and application knowledge. Nevertheless, the trend towards online shopping for beauty products continues to rise, and retailers are adapting to ensure that consumer safety and product efficacy remain paramount.

Others:

The "Others" category includes various distribution channels such as beauty salons and spas, where hyaluronic acid dermal fillers are increasingly being offered as part of aesthetic treatments. Many beauty establishments now incorporate filler injections into their service menus, catering to clients seeking non-surgical enhancements. This trend has emerged due to the growing popularity of cosmetic procedures and the desire for more accessible options outside of clinical settings. Practitioners in these environments often undergo specialized training to administer fillers safely, ensuring that clients receive quality service. As the market evolves, the inclusion of hyaluronic acid fillers in beauty establishments can significantly broaden the consumer base and encourage more individuals to explore aesthetic treatments.

By Ingredient Type

Stabilized Hyaluronic Acid:

Stabilized hyaluronic acid is a key ingredient in many dermal fillers, known for its enhanced longevity and performance in cosmetic applications. The stabilization process minimizes the degradation of hyaluronic acid, allowing for extended results after injection. This ingredient not only provides hydration but also promotes structural integrity within the skin, making it ideal for volumizing and contouring procedures. As consumers increasingly seek long-lasting results from their treatments, the demand for stabilized hyaluronic acid fillers has grown significantly. Furthermore, advancements in stabilization technology continue to improve the efficacy and safety of these products, positioning them as a preferred choice in the aesthetic market.

Non-Animal Stabilized Hyaluronic Acid:

Non-animal stabilized hyaluronic acid (NASHA) has gained popularity as a biocompatible alternative, characterized by its ability to minimize allergic reactions and improve patient safety. Derived from bacterial fermentation, NASHA retains the hydrophilic properties of hyaluronic acid, offering effective hydration and volume restoration without the risks associated with animal-based sources. This ingredient is particularly appealing to consumers who prioritize safety and ethical considerations in their cosmetic treatments. The increasing awareness of product ingredients and their origins has led to a trend towards non-animal stabilized hyaluronic acid in cosmetic fillers, reflecting a shift towards transparency and consumer empowerment in the market.

By Region

The North American region is expected to dominate the hyaluronic acid dermal filler market, accounting for approximately 40% of the global market share by 2035. The United States, in particular, is at the forefront of aesthetic advancements, with a high acceptance rate for cosmetic procedures among its population. Factors such as a robust healthcare system, increased disposable income, and a culture that values beauty and aesthetics contribute significantly to the growth of this market in North America. Additionally, the presence of leading manufacturers and a wide variety of product offerings further enhance market growth in this region, driving innovations and setting trends that influence global markets.

In Europe, hyaluronic acid dermal fillers are also witnessing substantial growth, with an expected CAGR of 9.6% from 2025 to 2035. Countries like Germany, France, and the UK are leading the market, propelled by an increasing number of aesthetic clinics and an expanding consumer base interested in non-surgical procedures. The rise of social media and the influence of celebrity culture in Europe have played significant roles in promoting the benefits of dermal fillers, leading to an uptick in demand. Furthermore, the regulatory environment in Europe encourages product safety and effectiveness, instilling consumer confidence in hyaluronic acid fillers, which is essential for sustained market expansion.

Opportunities

The Hyaluronic Acid Dermal Filler market presents a plethora of opportunities, particularly in the realm of product innovation and technology advancements. As consumer preferences evolve, there is a pressing demand for new formulations that provide longer-lasting effects and improved safety profiles. Manufacturers can capitalize on this trend by developing next-generation fillers that incorporate novel ingredients or advanced delivery systems to enhance product performance. Additionally, leveraging digital platforms to educate consumers about the benefits and safety of hyaluronic acid dermal fillers can significantly increase awareness and acceptance. By investing in R&D and fostering collaborations with industry experts, companies can position themselves as leaders in this competitive landscape, paving the way for significant market growth.

Another promising opportunity lies in expanding market reach within emerging economies, where the demand for aesthetic treatments is on the rise. Countries in Asia Pacific and Latin America are experiencing shifts in consumer behavior, with an increasing number of individuals seeking non-invasive cosmetic enhancements. By establishing a presence in these markets through strategic partnerships, targeted marketing, and localized product offerings, companies can tap into a burgeoning customer base. Additionally, the emphasis on personalized aesthetic treatments presents a unique avenue for growth, allowing practitioners to customize filler applications based on individual needs and preferences. As the market continues to evolve, adaptability and responsiveness to consumer trends will be crucial for success.

Threats

Despite the promising outlook for the Hyaluronic Acid Dermal Filler market, several threats could hinder its growth potential. One of the primary concerns is the increasing competition from alternative aesthetic treatments, such as laser therapies and other non-invasive procedures. As new technologies and methodologies emerge, consumers may opt for these alternatives instead of traditional fillers, which could result in a decline in market share for hyaluronic acid products. Additionally, the proliferation of counterfeit fillers poses a significant risk to the industry, compromising product safety and consumer trust. Regulatory bodies are tightening guidelines to combat this issue, but ensuring the authenticity of products remains a challenge that requires ongoing vigilance from manufacturers and practitioners alike.

Furthermore, changing consumer attitudes towards aesthetic treatments, influenced by cultural perceptions and economic factors, can also pose challenges. Economic downturns or shifts in consumer spending can lead to reduced expenditure on non-essential services like cosmetic enhancements. As aesthetic procedures are often viewed as luxury items, any negative shift in economic conditions could directly impact the demand for hyaluronic acid dermal fillers. To mitigate these threats, companies must stay attuned to market trends, engage in proactive consumer education, and emphasize the long-term benefits of their products to maintain a competitive edge in a dynamic marketplace.

Competitor Outlook

• Allergan (AbbVie)
• Revance Therapeutics, Inc.
• Galderma
• Medytox Inc.
• Hugel, Inc.
• Ipsen S.A.
• Revance Therapeutics, Inc.
• Merz Pharmaceuticals
• Hyaluronic Acid Products
• Prollenium Medical Technologies
• Baumer S.A.
• Hugel, Inc.
• Medytox Inc.
• Suneva Medical, Inc.
• Hugel, Inc.

The competitive landscape of the Hyaluronic Acid Dermal Filler market is characterized by a diverse array of players ranging from established giants to innovative startups. Major companies like Allergan, Galderma, and Revance Therapeutics dominate the market due to their extensive portfolios, robust R&D capabilities, and strong distribution networks. These companies continuously invest in innovation to develop new products that cater to ever-evolving consumer demands, ensuring they maintain their competitive advantage. The market is also seeing an influx of smaller players who are focusing on niche segments or unique formulations to differentiate themselves, leading to an increasingly fragmented landscape.

Allergan, a subsidiary of AbbVie, is a prominent player in the hyaluronic acid dermal filler market, known for its flagship product, Juvederm. With a strong emphasis on innovation, Allergan continually expands its product line to include various formulations tailored for specific applications, such as wrinkle correction and lip augmentation. Their commitment to consumer education and safety further enhances their brand reputation, making them a leader in the field. Additionally, Galderma, known for the Restylane brand, has also carved out a significant market presence, focusing on both product efficacy and patient satisfaction. Their products are widely recognized for delivering natural-looking results, which resonates well with the current trend towards subtlety in cosmetic enhancements.

In addition to these established names, companies like Medytox and Revance Therapeutics are emerging as key competitors in the hyaluronic acid filler market. Medytox specializes in innovative injectable products, leveraging advanced technology to enhance product stability and effectiveness. Meanwhile, Revance Therapeutics is making waves with its new DaxibotulinumtoxinA injection, which aims to offer longer-lasting results compared to traditional fillers. This innovation-driven approach is likely to influence market dynamics as consumers increasingly seek out cutting-edge treatments. As competition intensifies, companies must remain agile, investing in research and development to stay ahead of the curve and meet the demands of a rapidly changing market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Galderma
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ipsen S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Baumer S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hugel, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medytox Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Allergan (AbbVie)
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Merz Pharmaceuticals
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Suneva Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hyaluronic Acid Products
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Revance Therapeutics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Prollenium Medical Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hyaluronic Acid Dermal Filler Sales Market, By Application
    • 6.1.1 Wrinkle Correction
    • 6.1.2 Lip Augmentation
    • 6.1.3 Cheek Filling
    • 6.1.4 Scar Treatment
    • 6.1.5 Others
  • 6.2 Hyaluronic Acid Dermal Filler Sales Market, By Product Type
    • 6.2.1 Single-Phase
    • 6.2.2 Dual-Phase
    • 6.2.3 Reverse-Phase
    • 6.2.4 Cross-Linked
    • 6.2.5 Non-Cross-Linked
  • 6.3 Hyaluronic Acid Dermal Filler Sales Market, By Ingredient Type
    • 6.3.1 Stabilized Hyaluronic Acid
    • 6.3.2 Non-Animal Stabilized Hyaluronic Acid
  • 6.4 Hyaluronic Acid Dermal Filler Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Dermatology Clinics
    • 6.4.3 Online Retailers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hyaluronic Acid Dermal Filler Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hyaluronic Acid Dermal Filler Sales market is categorized based on

By Product Type

• Single-Phase
• Dual-Phase
• Reverse-Phase
• Cross-Linked
• Non-Cross-Linked

By Application

• Wrinkle Correction
• Lip Augmentation
• Cheek Filling
• Scar Treatment
• Others

By Distribution Channel

• Hospitals
• Dermatology Clinics
• Online Retailers
• Others

By Ingredient Type

• Stabilized Hyaluronic Acid
• Non-Animal Stabilized Hyaluronic Acid

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Allergan (AbbVie)
• Revance Therapeutics, Inc.
• Galderma
• Medytox Inc.
• Hugel, Inc.
• Ipsen S.A.
• Revance Therapeutics, Inc.
• Merz Pharmaceuticals
• Hyaluronic Acid Products
• Prollenium Medical Technologies
• Baumer S.A.
• Hugel, Inc.
• Medytox Inc.
• Suneva Medical, Inc.
• Hugel, Inc.